UFP Technologies, Inc.

UFPT · NasdaqCM · Stock · Healthcare
$297.13
+2.07% today
Delayed price,

What UFP Technologies does

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Key facts

Sector
Healthcare
Industry
Medical Devices
Market cap
$2.30B
P/E (ttm)
32.5
Forward P/E
25.0
Dividend yield
0.00%
Beta
1.03
Profit margin
11.4%
Employees
4,846
Headquarters
Newburyport, MA, United States
Exchange
NasdaqCM

Performance

1 Month
+7.4%
3 Months
+22.8%
6 Months
+46.8%
1 Year
+51.9%
5 Years
+344.3%
$173.8652-week range$338.71
Biggest setback — last 12 months
-29.1%
2 Feb 2026 → 23 Mar 2026
Fell from $267.34 to $189.45 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+69.8%
23 Mar 2026 → 10 Aug 2026
Ran from $189.45 to $321.76 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$257.10 (-13.5%)$297.13$343.39 (+15.6%)
3 Months$231.26 (-22.2%)$297.13$381.77 (+28.5%)
6 Months$208.45 (-29.8%)$297.13$423.53 (+42.5%)
12 Months$179.99 (-39.4%)$297.13$490.51 (+65.1%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 50.1%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Sold 7,000 shares at $305.07 — KOZIN MARC D, Director · 2026-08-27
Sold 298 shares at $319.11 — Hudson Symeria, Director · 2026-08-19
Sold 3,122 shares at $324.58 — Hudson Symeria, Director · 2026-08-17
Sold 1,000 shares at $324.26 — FELDMANN CYNTHIA L, Director · 2026-08-17
Sold 13,011 shares at $317.27 — BAILLY R JEFFREY, Executive Chairman · 2026-08-11
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.